Deloitte's view of the future: empowered consumers taking advantage of open, secure platforms that intermingle disparate information for care coordination and wellness "nudges." Now we just need to get there.

In its decision to approve two drugs for orange and grapefruit trees, the E.P.A. largely ignored objections from the C.D.C. and the F.D.A., which fear that expanding their use in cash crops could fuel antibiotic resistance in humans.